Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

282 - The clinical significance of lncRNA DANCR in upper rectal adenocarcinoma

Date

05 Mar 2018

Session

Poster display

Presenters

Fuat Aksoy

Citation

Annals of Oncology (2018) 29 (suppl_3): iii10-iii34. 10.1093/annonc/mdy047

Authors

F. Aksoy1, S. aksoy2, B. Tunca3, O. Işik4, E. Ozturk4, T. Yilmazlar4, O. Yerci5, U. Egeli3, G. Cecener3

Author affiliations

  • 1 General Surgery, Uludag University Medical Faculty, 16059 - Bursa/TR
  • 2 Medical Biology, Uludag University Medical Faculty, 16059 - Bursa/TR
  • 3 Medical Biology, Uludag University Medical Faculty, Bursa/TR
  • 4 General Surgery, Uludag University Medical Faculty, Bursa/TR
  • 5 Pathology, Uludag University Medical Faculty, Bursa/TR
More

Resources

Abstract 282

Long noncoding RNAs (lncRNAs) are dysregulated in many cancer types and are believed to play crucial roles in regulating several hallmarks of cancer biology. However, the clinical significance of the lncRNA DANCR in rectal cancer is unclear. This study aims to investigate the prognostic value of lncRNA DANCR in upper rectal cancer patients.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings